Immuneering (IMRX) Intangibles (2021 - 2026)
Immuneering (IMRX) reported Intangibles of $299,197 for Q3 2026, down 8.9% from $328,463 a year earlier and down 2.4% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Intangibles (2021 - 2026) Analysis & Trends
At the end of FY2025, Immuneering posted Intangibles of $321,147, down 8.4% from FY2024.
- Intangibles has declined for four consecutive years, with a four-year compound annual growth rate of -7.5% (FY2021 to FY2025).
- By year, Intangibles came in at $350,413 in FY2024 (-7.7%), $379,680 in FY2023 (-7.2%), $408,947 in FY2022 (-6.8%) and $439,000 in FY2021.
- The Q3 2026 figure ranks as the lowest quarterly Intangibles in data going back to Q4 2021.
- Year over year, Intangibles has now declined in each of the last 16 quarters, with an average decline of 8.3% over the last eight quarters.
- Over the past five years, the year-over-year decline in Intangibles ranged from 6.8% (Q1 2023) to 8.9% (Q3 2026).
- Per Business Quant data, the three quarters before Q3 2026 came in at $306,513 (Q2 2026), $313,830 (Q1 2026) and $321,147 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - | 299,197.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 299,197.00 |
| Jun 30, 2026 | 306,513.00 |
| Mar 31, 2026 | 313,830.00 |
| Dec 31, 2025 | 321,147.00 |
| Sep 30, 2025 | 328,463.00 |
| Jun 30, 2025 | 335,780.00 |
| Mar 31, 2025 | 343,097.00 |
| Dec 31, 2024 | 350,413.00 |
| Sep 30, 2024 | 357,730.00 |
| Jun 30, 2024 | 365,047.00 |
| Mar 31, 2024 | 372,363.00 |
| Dec 31, 2023 | 379,680.00 |
| Sep 30, 2023 | 386,997.00 |
| Jun 30, 2023 | 394,313.00 |
| Mar 31, 2023 | 401,630.00 |
| Dec 31, 2022 | 408,947.00 |
| Sep 30, 2022 | 416,263.00 |
| Jun 30, 2022 | 423,580.00 |
| Mar 31, 2022 | 430,897.00 |
| Dec 31, 2021 | 439,000.00 |
API Access
Immuneering Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();